Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other financing activities: 2020-2024

Historic Other financing activities for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to $37.8 million.

  • Cullinan Therapeutics' Other financing activities fell 71.95% to $7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $30.4 million, marking a year-over-year decrease of 35.58%. This contributed to the annual value of $37.8 million for FY2024, which is 24.27% up from last year.
  • As of FY2024, Cullinan Therapeutics' Other financing activities stood at $37.8 million, which was up 24.27% from $30.4 million recorded in FY2023.
  • Cullinan Therapeutics' Other financing activities' 5-year high stood at $37.8 million during FY2024, with a 5-year trough of $14.9 million in FY2020.
  • Moreover, its 3-year median value for Other financing activities was $30.4 million (2023), whereas its average is $32.1 million.
  • Data for Cullinan Therapeutics' Other financing activities shows a peak YoY surged of 63.48% (in 2021) over the last 5 years.
  • Over the past 5 years, Cullinan Therapeutics' Other financing activities (Yearly) stood at $14.9 million in 2020, then skyrocketed by 63.48% to $24.4 million in 2021, then rose by 14.70% to $28.0 million in 2022, then climbed by 8.87% to $30.4 million in 2023, then grew by 24.27% to $37.8 million in 2024.